Some small molecule NFκB inhibitors, such as pyrrolidine dithiocarbamate ammonium (PDTC), are also currently being investigated for the treatment of various inflammatory diseases, such as acute pancreatitis-like illness (13), cardiac inflammation (45), and rheumatoid arthritis. The gene discussed is NFKB1; the disease is rheumatoid arthritis.